RT Book, Section
A1 Massalha, S.
A1 Beanlands, Rob S.
A1 Small, Gary R.
A2 Heller, Gary V.
A2 Bateman, Timothy M.
A2 Case, James A.
A2 Arumugam, Parthiban
SR Print(0)
ID 1159185134
T1 Cardiac PET Myocardial Viability Assessment: Emerging Clinical Data
T2 Cardiovascular PET: Current Concepts
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259860485
LK accesscardiology.mhmedical.com/content.aspx?aid=1159185134
RD 2024/04/19
AB The  utility  of  myocardial  viability  imaging  hinges  on  the  premise  that  recovery  of  left  ventricular  (LV)  function  in  ischemic  heart  disease  can  be  achieved  through  coronary  revascularization  and  results  in  improved  outcomes  and  quality  of  life.  Rahimtoola  first  characterized  that  chronic  impaired  coronary  perfusion  resulted  in  impaired  contractility,  which  he  termed  hibernation.1  He  suggested  that  a  heart  with  reduced  LVEF  from  hibernation  could  be  improved  by  revascularization.  The  challenge  since  that  time  has  been  for  viability  imaging  to  identify  those  patients  whose  hearts  will  recover  function  and  who  will  subsequently  experience  improvement  in  quality  of  life.  It  is  a  challenge  that  remains  valid  and  alive  30  years  after  those  early  descriptions.